Jpmorgan Chase & CO Sangamo Therapeutics, Inc Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,207 shares of SGMO stock, worth $6,029. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,207

Previous 3,207 -0.0%

Holding current value

$6,029

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.36 - $0.65 $474,962 - $857,571	-1,319,341 Reduced 99.76%	3,207 $1,000
Q1 2024 May 10, 2024	SELL	$0.42 - $1.38 $21,305 - $70,003	-50,727 Reduced 3.69%	1,322,548 $886,000
Q4 2023 Feb 12, 2024	SELL	$0.3 - $0.63 $9,861 - $20,708	-32,871 Reduced 2.34%	1,373,275 $741,000
Q3 2023 Nov 14, 2023	SELL	$0.58 - $1.47 $44,236 - $112,116	-76,270 Reduced 5.14%	1,406,146 $843,000
Q2 2023 Aug 11, 2023	SELL	$1.11 - $1.74 $101,849 - $159,655	-91,756 Reduced 5.83%	1,482,416 $1.93 Million
Q1 2023 May 18, 2023	BUY	$1.66 - $3.67 $280,033 - $619,110	168,695 Added 12.0%	1,574,172 $2.77 Million
Q1 2023 May 11, 2023	SELL	$1.66 - $3.67 $260,341 - $575,573	-156,832 Reduced 10.04%	1,405,477 $2.47 Million
Q4 2022 Feb 13, 2023	BUY	$2.77 - $5.07 $52,064 - $95,295	18,796 Added 1.22%	1,562,309 $4.91 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $140,120 - $209,687	32,815 Added 2.17%	1,543,513 $7.56 Million
Q2 2022 Aug 11, 2022	BUY	$3.28 - $6.21 $29,159 - $55,206	8,890 Added 0.59%	1,510,698 $6.25 Million
Q1 2022 May 11, 2022	SELL	$5.23 - $7.82 $429,806 - $642,655	-82,181 Reduced 5.19%	1,501,808 $8.73 Million
Q4 2021 Feb 10, 2022	SELL	$7.29 - $10.97 $3.16 Million - $4.76 Million	-433,487 Reduced 21.49%	1,583,989 $11.9 Million
Q3 2021 Nov 12, 2021	BUY	$9.01 - $12.01 $18.2 Million - $24.2 Million	2,017,476 New	2,017,476 $18.2 Million

Others Institutions Holding SGMO

# of Institutions

115

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $294M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Sangamo Therapeutics, Inc Transaction History